INNOVIVA, INC. Increase (Decrease) in Accounts Payable
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Accounts Payable of -$950.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- INNOVIVA, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$2.50M, a 466.86% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.55M, a 39.56% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.28M.
- INNOVIVA, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $861.00K, a 59.60% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in accounts payable for fiscal 2025 was $2.83M.
- INNOVIVA, INC. increase (decrease) in accounts payable for fiscal 2024 was -$4.58M, a 221.36% decline from fiscal 2023.
- INNOVIVA, INC. increase (decrease) in accounts payable for fiscal 2023 was $3.78M, a 4006.52% increase from fiscal 2022.
- INNOVIVA, INC. increase (decrease) in accounts payable for fiscal 2022 was $92.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$950.00K 10-Q · filed 2026-08-05 | -$2.23M derived: sum of 3 quarters · filed 2026-08-05 | -$1.37M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-06 | $275.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.14M derived: sum of 3 quarters · filed 2026-05-06 | $1.82M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$416.00K derived: sum of 2 quarters · filed 2026-02-25 | $266.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.83M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $861.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.54M derived: sum of 2 quarters · filed 2026-08-05 | $4.11M 10-Q · filed 2025-11-05 | $2.07M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $682.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.25M 10-Q · filed 2026-08-05 | $1.21M derived: sum of 3 quarters · filed 2026-08-05 | $3.34M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $2.57M 10-Q · filed 2026-05-06 | $530.00K derived: sum of 2 quarters · filed 2026-05-06 | $2.66M derived: sum of 3 quarters · filed 2026-05-06 | $3.81M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $93.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.24M derived: sum of 3 quarters · filed 2026-02-25 | -$4.58M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.28M derived: sum of 2 quarters · filed 2025-11-05 | -$2.55M 10-Q · filed 2025-11-05 | $387.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.68M 10-Q · filed 2025-08-06 | -$1.74M derived: sum of 3 quarters · filed 2026-02-25 | -$2.55M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | -$5.83M 10-Q · filed 2025-05-07 | -$2.89M derived: sum of 2 quarters · filed 2026-02-25 | -$3.70M derived: sum of 3 quarters · filed 2026-02-25 | -$5.04M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.13M derived: sum of 2 quarters · filed 2026-02-25 | $784.00K derived: sum of 3 quarters · filed 2026-02-25 | $3.78M 10-K · filed 2026-02-25 | |
| 2023-09-30 | -$809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$2.15M derived: sum of 2 quarters · filed 2024-11-06 | $844.00K 10-Q · filed 2024-11-06 | -$22.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $1.65M 10-Q · filed 2024-07-31 | $787.00K derived: sum of 3 quarters · filed 2025-02-26 | -$968.00K derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $2.99M 10-Q · filed 2024-05-08 | $2.13M derived: sum of 2 quarters · filed 2025-02-26 | $373.00K derived: sum of 3 quarters · filed 2025-02-26 | $2.89M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | -$866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$2.62M derived: sum of 2 quarters · filed 2025-02-26 | -$106.00K derived: sum of 3 quarters · filed 2025-02-26 | $92.00K 10-K · filed 2025-02-26 | |
| 2022-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $760.00K derived: sum of 2 quarters · filed 2023-11-01 | $958.00K 10-Q · filed 2023-11-01 | $896.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $2.71M 10-Q · filed 2023-08-02 | $2.65M derived: sum of 3 quarters · filed 2024-03-05 | $2.71M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $198.00K 10-Q · filed 2023-05-09 | $136.00K derived: sum of 2 quarters · filed 2024-03-05 | $195.00K derived: sum of 3 quarters · filed 2024-03-05 | $211.00K derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | -$62.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | -$3.00K derived: sum of 2 quarters · filed 2024-03-05 | $13.00K derived: sum of 3 quarters · filed 2024-03-05 | -$39.00K 10-K/A · filed 2024-03-05 | |
| 2021-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $75.00K derived: sum of 2 quarters · filed 2022-11-09 | $23.00K 10-Q · filed 2022-11-09 | -$534.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$36.00K 10-Q · filed 2022-07-27 | -$593.00K derived: sum of 3 quarters · filed 2023-02-28 | -$165.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$52.00K 10-Q · filed 2022-05-05 | -$609.00K derived: sum of 2 quarters · filed 2023-02-28 | -$181.00K derived: sum of 3 quarters · filed 2023-02-28 | -$108.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$129.00K derived: sum of 2 quarters · filed 2023-02-28 | -$56.00K derived: sum of 3 quarters · filed 2023-02-28 | $56.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $501.00K derived: sum of 2 quarters · filed 2021-10-27 | $613.00K 10-Q · filed 2021-10-27 | $588.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $185.00K 10-Q · filed 2021-07-29 | $160.00K derived: sum of 3 quarters · filed 2022-03-17 | -$944.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-03-31 | $112.00K 10-Q · filed 2021-04-28 | $87.00K derived: sum of 2 quarters · filed 2022-03-17 | -$1.02M derived: sum of 3 quarters · filed 2022-03-17 | -$22.00K derived: sum of 4 quarters · filed 2022-03-17 | |
| 2019-12-31 | -$25.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | -$1.13M derived: sum of 2 quarters · filed 2022-03-17 | -$134.00K derived: sum of 3 quarters · filed 2022-03-17 | -$1.00K 10-K/A · filed 2022-03-17 | |
| 2019-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$109.00K derived: sum of 2 quarters · filed 2020-10-28 | $24.00K 10-Q · filed 2020-10-28 | -$74.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $995.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.13M 10-Q · filed 2020-07-29 | $1.03M derived: sum of 3 quarters · filed 2021-02-25 | $1.08M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $133.00K 10-Q · filed 2020-04-29 | $35.00K derived: sum of 2 quarters · filed 2021-02-25 | $86.00K derived: sum of 3 quarters · filed 2021-02-25 | $78.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$47.00K derived: sum of 2 quarters · filed 2021-02-25 | -$55.00K derived: sum of 3 quarters · filed 2021-02-25 | -$590.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $43.00K derived: sum of 2 quarters · filed 2019-10-30 | -$492.00K 10-Q · filed 2019-10-30 | -$520.00K derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$543.00K 10-Q · filed 2019-07-24 | -$571.00K derived: sum of 3 quarters · filed 2020-02-19 | -$219.00K derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-03-31 | -$535.00K 10-Q · filed 2019-05-01 | -$563.00K derived: sum of 2 quarters · filed 2020-02-19 | -$211.00K derived: sum of 3 quarters · filed 2020-02-19 | -$2.24M derived: sum of 4 quarters · filed 2020-02-19 | |
| 2017-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $324.00K derived: sum of 2 quarters · filed 2020-02-19 | -$1.70M derived: sum of 3 quarters · filed 2020-02-19 | $473.00K 10-K · filed 2020-02-19 | |
| 2017-09-30 | $352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$1.68M derived: sum of 2 quarters · filed 2018-10-31 | $501.00K 10-Q · filed 2018-10-31 | $101.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $149.00K 10-Q · filed 2018-07-26 | -$251.00K derived: sum of 3 quarters · filed 2019-02-19 | $140.00K derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-03-31 | $2.18M 10-Q · filed 2018-05-04 | $1.78M derived: sum of 2 quarters · filed 2019-02-19 | $2.17M derived: sum of 3 quarters · filed 2019-02-19 | $1.73M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2016-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$9.00K derived: sum of 2 quarters · filed 2019-02-19 | -$448.00K derived: sum of 3 quarters · filed 2019-02-19 | -$690.00K 10-K · filed 2019-02-19 | |
| 2016-09-30 | $391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$48.00K derived: sum of 2 quarters · filed 2017-11-03 | -$290.00K 10-Q · filed 2017-11-03 | $374.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2016-06-30 | -$439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$681.00K 10-Q · filed 2017-08-08 | -$17.00K derived: sum of 3 quarters · filed 2018-02-23 | -$325.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2016-03-31 | -$242.00K 10-Q · filed 2017-05-05 | $422.00K derived: sum of 2 quarters · filed 2018-02-23 | $114.00K derived: sum of 3 quarters · filed 2018-02-23 | -$449.00K derived: sum of 4 quarters · filed 2018-02-23 | |
| 2015-12-31 | $664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $356.00K derived: sum of 2 quarters · filed 2018-02-23 | -$207.00K derived: sum of 3 quarters · filed 2018-02-23 | $818.00K 10-K · filed 2018-02-23 | |
| 2015-09-30 | -$308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$871.00K derived: sum of 2 quarters · filed 2016-11-03 | $154.00K 10-Q · filed 2016-11-03 | -$419.00K derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-06-30 | -$563.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $462.00K 10-Q · filed 2016-08-04 | -$111.00K derived: sum of 3 quarters · filed 2017-02-28 | -$1.40M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-03-31 | $1.02M 10-Q · filed 2016-05-05 | $452.00K derived: sum of 2 quarters · filed 2017-02-28 | -$838.00K derived: sum of 3 quarters · filed 2017-02-28 | -$5.50M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2014-12-31 | -$573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$1.86M derived: sum of 2 quarters · filed 2017-02-28 | -$6.52M derived: sum of 3 quarters · filed 2017-02-28 | -$7.70M 10-K · filed 2017-02-28 | |
| 2014-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$5.95M derived: sum of 2 quarters · filed 2015-11-05 | -$7.12M 10-Q · filed 2015-11-05 | -$7.55M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-30 | -$4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$5.83M 10-Q · filed 2015-08-06 | -$6.26M derived: sum of 3 quarters · filed 2016-02-24 | -$5.25M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-03-31 | -$1.17M 10-Q · filed 2015-05-08 | -$1.60M derived: sum of 2 quarters · filed 2016-02-24 | -$587.00K derived: sum of 3 quarters · filed 2016-02-24 | $660.00K derived: sum of 4 quarters · filed 2016-02-24 | |
| 2013-12-31 | -$427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $587.00K derived: sum of 2 quarters · filed 2016-02-24 | $1.83M derived: sum of 3 quarters · filed 2016-02-24 | $1.61M 10-K · filed 2016-02-24 | |
| 2013-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $2.26M derived: sum of 2 quarters · filed 2014-11-04 | $2.04M 10-Q · filed 2014-11-04 | $1.01M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.03M 10-Q · filed 2014-08-07 | -$2.00K derived: sum of 3 quarters · filed 2015-02-27 | -$373.00K derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$221.00K 10-Q · filed 2014-05-07 | -$1.25M derived: sum of 2 quarters · filed 2015-02-27 | -$1.62M derived: sum of 3 quarters · filed 2015-02-27 | -$1.75M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$1.40M derived: sum of 2 quarters · filed 2015-02-27 | -$1.53M derived: sum of 3 quarters · filed 2015-02-27 | -$1.48M 10-K · filed 2015-02-27 | |
| 2012-09-30 | -$371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$500.00K derived: sum of 2 quarters · filed 2013-11-01 | -$452.00K 10-Q · filed 2013-11-01 | $1.41M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-06-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$81.00K 10-Q · filed 2013-08-01 | $1.78M derived: sum of 3 quarters · filed 2014-03-03 | $2.42M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-03-31 | $48.00K 10-Q · filed 2013-05-01 | $1.91M derived: sum of 2 quarters · filed 2014-03-03 | $2.54M derived: sum of 3 quarters · filed 2014-03-03 | $3.16M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2011-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $2.50M derived: sum of 2 quarters · filed 2014-03-03 | $3.11M derived: sum of 3 quarters · filed 2014-03-03 | $3.31M 10-K · filed 2014-03-03 | $3.31M 10-K · filed 2012-02-27 |
| 2011-09-30 | $633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $1.25M derived: sum of 2 quarters · filed 2012-10-31 | $1.45M 10-Q · filed 2012-10-31 | $1.12M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $813.00K 10-Q · filed 2012-08-01 | $483.00K derived: sum of 3 quarters · filed 2013-02-26 | $860.00K derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | $198.00K 10-Q · filed 2012-05-02 | -$132.00K derived: sum of 2 quarters · filed 2013-02-26 | $245.00K derived: sum of 3 quarters · filed 2013-02-26 | ||
| 2010-12-31 | -$330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $47.00K derived: sum of 2 quarters · filed 2013-02-26 | -$236.00K 10-K · filed 2013-02-26 | ||
| 2010-09-30 | $377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $94.00K 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | -$283.00K 10-Q · filed 2011-08-03 | ||||
| 2009-12-31 | -$1.63M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |